Since their introduction in 1981, ventricular late potentials

Size: px
Start display at page:

Download "Since their introduction in 1981, ventricular late potentials"

Transcription

1 Sudden Cardiac Death After Coronary Artery Bypass Grafting Is Not Predicted by Signal- Averaged ECG Christoph Scharf, MD, Hermann Redecker, MD, Firat Duru, MD, Reto Candinas, MD, Hans Peter Brunner-La Rocca, MD, Andreas Gerber, MD, Osmund Bertel, MD, Marko I. Turina, MD, and Wolfgang Kiowski, MD Divisions of Cardiology and Cardiovascular Surgery, University Hospital, Zurich, and Division of Cardiology, Stadtspital Triemli, Zurich, Switzerland Background. Sudden cardiac death (SCD) is a major cause of death despite successful revascularization in patients with coronary artery disease. The signalaveraged ECG (SAECG) is a sensitive predictor of SCD and could be used in the screening strategy to select patients for prophylactic cardioverter implantation. Methods. The SAECG was recorded in 561 patients (mean age: years) within 10 days of coronary artery bypass grafting. Signal-averaged ECG was performed with a bandpass filtering of 40 to 250 Hz for more than 250 beats until a noise level of 0.6 V was achieved. All patients were followed for years after the procedure. Results. Preoperative angiographic ejection fraction was at least 60% in 393 patients (72%), 40% to 60% in 126 patients (23%), and 40% or less in 28 patients (5%). There were 34 deaths, 10 of which were SCD. Late potentials were found in a total of 150 patients (27%) and were equally frequent preoperatively and postoperatively and among patients with (30%) and without (27%) SCD. The only predictors for overall mortality were age and a reduced ejection fraction. Conclusions. Signal-averaged ECG did not predict prognosis in low-risk patients undergoing coronary artery bypass grafting. (Ann Thorac Surg 2001;72: ) 2001 by The Society of Thoracic Surgeons Accepted for publication July 30, Address reprint requests to Dr Scharf, Division of Cardiology, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland; christoph.scharf@dim.usz.ch. Since their introduction in 1981, ventricular late potentials (LPs), as registered from signal-averaged ECG (SAECG) recordings, have been used in risk stratification of patients at risk for sudden cardiac death (SCD) [1]. These potentials are low-amplitude, high-frequency signals at the terminal portion of the QRS complex and reflect delayed ventricular depolarizations, which can be visualized by signal averaging and bandpass filtering of the surface ECG [2]. Their presence may indicate an arrhythmic substrate for reentry, especially in patients with coronary artery disease (CAD) [3, 4]. Late potentials have been advocated as predictors of SCD after myocardial infarction, with a high sensitivity and high negative predictive values [3, 5]. Many reports, however, date from the prethrombolytic era, and the patency of the infarct artery may critically affect the genesis and prognostic value of LPs [6]. Thus, bypass grafting to the infarctrelated artery has been associated with a reduction of LPs in some patients [7]. In addition, LPs predict perioperative arrhythmic events, but their predictive value in long-term follow-up after coronary artery bypass grafting (CABG) has been studied only in small series without long-term follow-up [8, 9]. Implantable cardioverter defibrillators (ICD) have been shown to provide effective prevention of SCD. However, most cases of SCD occur in low-risk patients who have not been identified by such well-known factors as reduced ejection fraction or sustained ventricular tachycardia [10]. The SAECG, as a noninvasive test with high sensitivity and negative predictive value, could easily identify patients who would not profit from an ICD. A pathologic SAECG recording was used to include patients in a CABG Patch Trial, which demonstrated no benefit from a prophylactic ICD [11]. However, the prognostic value of SAECG in patients undergoing revascularization has not been evaluated either in a large number of patients or in unselected patients. Therefore, to define the sensitivity to be used in a screening strategy, the SAECG was routinely recorded preoperatively and postoperatively in patients undergoing CABG at our institution. End points of the study were SCD and all-cause mortality. Patients and Methods Signal averaging of real-time electrocardiograms was routinely performed in 561 patients (74 female, 487 male) within 10 days of CABG. Patients who died perioperatively were excluded from analysis. Further exclusion criteria were absence of sinus rhythm, intraventricular conduction delay (duration of the unfiltered QRS com by The Society of Thoracic Surgeons /01/$20.00 Published by Elsevier Science Inc PII S (01)

2 Ann Thorac Surg SCHARF ET AL 2001;72: SIGNAL-AVERAGED ECG AS A PREDICTOR OF SCD 1547 Table 1. Characteristics of Survivors, Nonsurvivors and Patients With SCD Survivors (n 527) Dead (n 34) Difference (t-test) SCD (n 10) LPs preoperatively 96 5 a ns 3 a LPs postoperatively 80 4 a ( a one both) ns 1 a ( a one both) LPs neither pre- nor 385 (73%) 26 (76%) ns 7 (70%) postoperatively dqrs (ms) ns LAS40 (ms) ns RMS40 ( V) ns Age at operation (years) p Ejection fraction 40% 24 (5%) 4 (12%) ns 2 40% 60% 118 (23%) 8 (25%) ns 3 60% 372 (72%) 21 (65%) ns 4 No ventriculogram preoperatively RCA occluded 132 (25%) 11 (32%) p LAD occluded 97 (18%) 9 (26%) ns 2 LCX occluded 76 (14%) 6 (17%) p vessel disease 37 (7%) 4 (11%) ns 0 2-vessel disease 108 (20%) 5 (14%) ns 1 3-vessel disease 379 (72%) 25 (73%) ns 9 Number of grafts per patient ns 4 Arterial revascularization 462 (88%) 22 (64%) p Extracorporeal circulation (min) p Aortic cross-clamping time (min) ns Values are expressed as number of patients unless indicated otherwise. Age was the only predictor of overall survival, and a reduced ejection fraction was the only predictor of SCD on survival analysis (Cox regression). a One patient had both LPs preoperatively and postoperatively in the group of Dead and SCD Patients. dqrs QRS duration; LAD left anterior descending; LAS low amplitude signal; LCX left circumflex coronary artery; LPs late potentials; ns not significant; RMS40 root mean square of the terminal 40 ms of the QRS complex; SCD sudden cardiac death. plex of more than 120 milliseconds), and a noise level above 0.6 V during recording. According to the standards for time domain analysis [2], real-time recording was performed using a Marquette MAC 15 HiRes ECG recorder (Milwaukee, WI), as previously described [8]. The QRS signal in the three orthogonal Frank leads was filtered (40 to 250 Hz) and averaged for 250 beats or more, until a noise level of 0.6 V or less was achieved. Three parameters were calculated: filtered QRS duration (dqrs, ms), duration of the terminal low-amplitude signal lower than 40 V (LAS40, ms), and the root mean square of the terminal 40 ms of the QRS complex (RMS40, V). The presence of LPs was defined when two of the following three criteria were met: dqrs longer than 120 ms, LAS40 at least 38 msec, and RMS40 lower than 20 V. Medical records of all patients were reviewed for clinical and angiographic findings. Follow-up of patients was achieved by telephone calls to patients, their relatives, or family physicians. In the case of death, the exact circumstances for each case were obtained from relatives, family physicians, review of medical records in the case of hospitalization, or state death chart registry. The primary end point of the study was SCD, which was defined as witnessed instant death, death occurring after cardiac arrest due to ventricular fibrillation, or unwitnessed death without preceding symptoms of any underlying disease or specific etiology. Secondary end points were all-cause mortality and cardiac death including heart failure and myocardial infarction. Predictors for survival were assessed using Cox regression for continuous variables and Kaplan-Meier analysis for discontinuous variables. Differences in patient characteristics and SAECG were assessed using the paired t-test and the Wilcoxon rank-sum test as appropriate. Values are expressed as mean standard deviation. Calculations were made using a commercially available statistical package (SPSS 9.0 for Windows; SPSS, Inc, Chicago, IL). A p-value less than 0.05 was considered statistically significant. Results Baseline Characteristics Clinical and angiographic characteristics of 561 patients discharged after CABG are summarized in Tables 1 and 2. Of the 561 patients with SAECG recordings, 439 had a preoperative recording, 460 had a postoperative recording, and 338 had both. The remaining SAECG were missing or had to be exluded because of noise artifacts, duration of unfiltered QRS longer than 120 milliseconds,

3 1548 SCHARF ET AL Ann Thorac Surg SIGNAL-AVERAGED ECG AS A PREDICTOR OF SCD 2001;72: Table 2. Preoperatively and Postoperative Findings in Patients With and Without Late Potentials Patients With LPs Either Pre- or Postoperatively (n 150) Patients Without LPs (n 411) Difference (t-test) Age at operation yr yr Ejection fraction 40% 9 (6%) 19 (4.6%) ns 40% 60% 35 (23%) 91 (22.1%) ns 60% 102 (68%) 291 (70.8%) ns No major vessel occluded 63 (42%) 204 (49.6%) ns RCA occluded 48 (32%) 95 (23%) p 0.05 RAD occluded 19 (18%) 87 (21%) p 0.05 RCX occluded 31 (20%) 51 (12%) p vessel disease 8 (5.3%) 33 (8%) ns 2-vessel disease 30 (20%) 82 (20%) ns 3-vessel disease 111 (74%) 294 (72%) ns Arterial revascularization (LIMA used) 128 (85%) 356 (89%) ns Extracorporeal circulation time min 90 min 30.3 min ns Aortic cross-clamping time min min ns Years of follow-up yr yr ns Sudden cardiac death 3 (2%) 7 (1.7%) ns Cardiac death 3 (2%) 12 (2.9%) ns Noncardiac death 5 (3.3%) 14 (3.4%) ns Alive 142 (94.2%) 385 (93.7%) ns LIMA left internal mammary artery; LPs late potentials; ns not significant; RAD right anterior descending coronary artery; RCA right coronary artery; RCX right circumflex coronary artery. postoperative atrial fibrillation, or time delay in recording for more than 10 days after the operation. Late potentials were found in 150 patients (27%) either pre- or postoperatively. Of these, 35 patients had both preoperative and postoperative LPs, 38 had preoperatively positive and postoperatively negative LPs, 25 had only one preoperative SAECG available showing LPs, 22 had only one postoperative SAECG available showing LPs, and in 30 a previously normal SAECG showed LPs postoperatively (Table 3). Patients with LPs did not differ from patients without LPs with respect to most clinical and perioperative variables, except for type of vessel occluded (Table 2). Of note, the occurrence of LPs was not related to impaired left ventricular function, or to prolonged aortic cross-clamping or extracorporeal circulation time. The occurrence of LPs was not significantly influenced by the operation, but the minor changes of SAECG were statistically significant ( p Wilcoxon rank sum test) (Table 3). However, the shortening of dqrs ( ms) and LAS40 (1 11 ms), as well as the increase of RMS40 ( V) were too small to result in a change in the occurrence of LPs. Also, differences between preand postoperative recordings of SAECG parameters were not correlated with any clinical or perioperative parameters, including duration of aortic cross-clamping or extracorporeal circulation time. Nor were they related to outcome. Preoperative LPs were highly predictive of postoperative LPs (chi square 47, p 0.001). Long-Term Follow-up Follow-up was available for all 561 patients for a mean of years, resulting in a total of 3,085 patient-years of follow-up. Thirty-four patients (6.5%) died during Table 3. Preoperative and Postoperative Finding of SAECG SAECG (LPs) n SCD dqrs (ms) LAS40 (ms) RMS40 ( V) Pre Post Pre Post Pre Post All patients a a a Both negative Negative 3 positive Positive 3 negative Both positive a Statistically significant differences ( p Wilcoxon rank sum test) only for the first row with all patients. These differences were too small to account for any significant changes in the occurrence of LPs. dqrs QRS duration; LAS40 low amplitude signal 40; LPs late potentials; RMS40 root mean square of the terminal 40 ms of the QRS complex; SAECG signal-averaged ECG; SCD sudden cardiac death.

4 Ann Thorac Surg SCHARF ET AL 2001;72: SIGNAL-AVERAGED ECG AS A PREDICTOR OF SCD 1549 Table 4. SAECG in the Ten Patients With Sudden Cardiac Death Age/Sex Mode of Death Preoperative SAECG Postoperative SAECG dqrs LAS40 RMS40 dqrs LAS40 RMS40 65/Male SCD witnessed /Male SCD witnessed a a a 77/Male SCD, possible AMI /Male SCD witnessed /Male SCD witnessed /Male SCD witnessed b 58/Male SCD witnessed /Male SCD witnessed /Male SCD witnessed /Male VF documented in hospital a Censored because unfiltered QRS 123 ms. b Censored because atrial fibrillation occurred postoperatively. AMI acute myocardial infarction; dqrs QRS duration; LAS40 low amplitude signal 40; RMS40 root mean square of the terminal 40 ms of the QRS complex; SAECG signal-averaged ECG; SCD sudden cardiac death; VF ventricular fibrillation. follow-up, for an annual mortality of 1.2% after hospital discharge. Sudden cardiac death occurred in ten patients (29% of total mortality). The frequency of SCD was constant during follow-up, with two to three cases per year. The earliest SCD occurred 2 days after hospital discharge, after an uneventful postoperative course. Preoperatively, this patient (with LPs) had exercise-induced ventricular tachycardia lasting for 15 seconds, which means that ventricular arrhythmia was the likely cause of death. Clinical and angiographic characteristics of patients with SCD are summarized in Table 1. Perioperative myocardial infarction occurred in one patient. One patient underwent concurrent CABG and aortic valve replacement, and SCD occurred after 5 years. In three other patients not classified as SCD, ventricular arrhythmia could have been responsible for subsequent death: one patient died of worsening heart failure and pneumonia 3 months after documented ventricular fibrillation and successful cardiopulmonary resuscitation, and two other patients died in accidents. Acute myocardial infarction was responsible for five deaths (15%). Thus, fifteen of thirty-four patients died from cardiovascular causes (44%). Cancer accounted for ten deaths (29%), stroke for three, pneumonia for two, accidents for two, hepatic cirrhosis for one, and suicide for one. Predictors of SCD and Total Mortality The clinical, angiographic, perioperative, and electrocardiographic characteristics of survivors, nonsurvivors, and patients with SCD are outlined in Table 1. Individual values in SAECG of all patients with SCD are summarized in Table 4. Importantly, LPs were equally frequent in patients with and without SCD (30% vs 27%) and identified only three of ten patients with SCD (sensitivity 30%). Because the prevalence of SCD was low (1.8%), the negative predictive value of a normal SAECG was 98% (7 false-negative and 406 true-negative). However, 98% of LPs were false-positive (specificity 73%). Survival analysis did not show any significant relationship between LPs and SCD, cardiac death, or all-cause mortality. Neither preoperative nor postoperative LPs alone predicted SCD. There was an insignificant trend in the relationship of mean duration of filtered QRS complex to overall survival ( p 0.078), but not with SCD. Of 80 patients with postoperative LPs, only four died and only one of those died suddenly during follow-up. Although the presence and localization of an occluded vessel and the type of revascularization performed were statistically different (t-test) between survivors and nonsurvivors (Table 1), survival analysis using Cox regression identified only age (Wald 7.19, p 0.01) as a predictor of overall survival and a reduced ejection fraction (Wald 5.0, p 0.05) as a predictor of SCD. Aortic cross-clamping time and extracorporeal circulation duration did not correlate with survival or cardiac death, including SCD, in survival analysis. Comment In this study with over 3,000 patient-years of follow-up after CABG, overall mortality was low, ie, 1.2% per year. However, SCD was one of the most frequent causes of death, together with malignancy, and accounted for approximately 30% of total mortality. The incidence of SCD was stable during follow-up and occurred most often in patients without any risk factors. Most importantly, SAECG did not predict mortality or SCD after CABG. An abnormal SAECG with positive LPs was found in 26.7% of our patients, similar to previous results [6, 8] and was not related to such clinical or perioperative factors as left ventricular function, number of occluded coronary arteries, type of revascularization performed, or aortic crossclamping time. Only the type of occluded coronary was correlated with the frequency of LPs, which were more common in right coronary artery or right circumflex artery occlusion than in left anterior descending coronary artery occlusion. We studied unselected patients at low risk, only 5% of whom had an ejection fraction below 40%. Nevertheless, a reduced ejection fraction was the only predictor of SCD ( p 0.05), which agrees with other large-scale studies

5 1550 SCHARF ET AL Ann Thorac Surg SIGNAL-AVERAGED ECG AS A PREDICTOR OF SCD 2001;72: like MADIT [12], MUSTT [13], and CIDS [14], in which patients with a severely reduced ejection fraction profited most from ICD implantation. The effect of prophylactic ICD implantation in patients undergoing CABG was tested in a large multicenter CABG Patch Trial [11]. Patients with an abnormal SAECG and a reduced left ventricular ejection fraction less than 36% were randomly assigned to an ICD implantation group during CABG [11]. No benefit from ICD implantation was seen, and this was explained by the low incidence of arrhythmic death [15]. Our data suggest, however, that most patients with subsequent SCD presented with a normal SAECG and presumably were missed by the inclusion criteria. To date only one study including 100 patients with short follow-up assessed the prognostic role of SAECG in patients undergoing CABG, which confirms our results [9]. Our data appear to be in contrast to many previous reports demonstrating a prognostic role for SAECG in CAD patients. There is no ready explanation for this discrepancy. However, since the landmark study by Simson in 1981 [16] and numerous other studies [5, 17], remarkable progress in treatment of acute and chronic CAD has lowered cardiac mortality substantially. It is conceivable that thrombolysis and early revascularization after myocardial infarction, as well as widespread use of beta blockers, statins, and ACE inhibitors have changed patient characteristics and might render findings on SAECG less important for predicting survival and SCD, as compared in patients studied before such therapies became widespread. Although surgical revascularization did not influence the occurrence of LPs, there was a discrete but significant nonlinear effect on SAECG parameters. The clinical significance of these minor changes remains unknown. The changes in the occurrence of LPs between pre- and postoperative SAECG recordings are randomly occurring, without prognostic implication and the analysis of these subgroups should not lead to any conclusions in our opinion. To date, the effect of revascularization on SAECG has been demonstrated mainly in acute coronary occlusion, and reperfusion [18]. Results indicating abolition of LPs after CABG have been obtained in only a few selected patients and have not been replicated [7]. Another finding of our study is that the duration of extracorporeal circulation and aortic cross-clamping does not influence SAECG parameters or long-term prognosis. The longer extracorporeal circulation time in nonsurvivors was due to prolonged warming of a subgroup of significantly older patients; thus, it was not an independent predictor of prognosis. This finding may reassure thoracic surgeons and anesthesiologists in the current practice of extracorporeal circulation. Limitations of This Study A major limitation of clinical follow-up studies is the diagnosis of SCD. However, all but one of our SCD cases were witnessed, and no specific symptoms were noted before the event in any case. Acute myocardial infarction seems to be less frequent in survivors of out-of-hospital ventricular fibrillation [19, 20]. We did not include three patients, in whom death could be attributed to arrhythmia: two accidents and one death from pulmonary complications 3 months after initially successful cardiopulmonary resuscitation from ventricular fibrillation. Two of these patients had LPs. Even if these cases were included in the survival analysis, the presence or absence of LPs would not predict SCD ( p 0.78 on Cox regression), and the sensitivity would rise from 30% (3 of 10) to 38% (5 of 13) only. Another limitation of our study is the lack of information about concomitant medication during long term follow-up, which is known to influence prognosis. The definition of an abnormal SAECG was prospectively defined [2]. Even when applying the criteria of previous studies by Simson [16], Kuchar and associates [5], or Gomes and colleagues [17], only 4 of 10 patients would have positive LPs, increasing the sensitivity to 40% (Table 3). As we followed a low-risk population undergoing routine CABG, a low number of end points was reached which may lead to a type II error and could explain the discrepancy with other reports. Because most SCD cases occur in low-risk patients not identified by traditional risk factors, however, it was the aim of our study to assess the predictive value of SAECG in unselected patients undergoing revascularization at our institution. In conclusion, the SAECG was not useful to predict prognosis in unselected patients undergoing CABG, and it does not appear to be helpful in a screening strategy for ICD implantation. References 1. Breithardt G, Becker R, Seipel L, Abendroth RR, Ostermeyer J. Non-invasive detection of late potentials in man a new marker for ventricular tachycardia. Eur Heart J 1981;2: Breithardt G, Cain ME, el Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circulation 1991;83: Breithardt G, Borggrefe M, Karbenn U, Abendroth RR, Yeh HL, Seipel L. Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings. Am J Cardiol 1982;49: El Sherif N, Scherlag BJ, Lazzara R, Hope RR. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone. Circulation 1977;55: Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signalaveraged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 1987;9: Hohnloser SH, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation 1994;90: Terada Y, Mitsui T, Matsushita S, Atsumi N, Jikuya T, Sakakibara Y. Influence of bypass grafting to the infarct artery on late potentials in coronary operations. Ann Thorac Surg 1995;60: Frielingsdorf J, Gerber AE, Laske A, Bertel O. Influence of

6 Ann Thorac Surg SCHARF ET AL 2001;72: SIGNAL-AVERAGED ECG AS A PREDICTOR OF SCD 1551 coronary artery bypass grafting on ventricular late potentials as a predictive factor for ventricular arrhythmias during short- and long-term follow-up. Eur Heart J 1995;16: Lacroix D, Kacet S, Dagano J, et al. Prognostic value and development of late potentials after aortocoronary bypass. A prospective study of 100 patients. Arch Mal Coeur Vaiss 1991;84: Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80:10F 19F. 11. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337: Moss AJ, Hall WJ, Cannon DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335: Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341: Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000; 101: Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99: Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981;64: Gomes JA, Winters SL, Martinson M, Machac J, Stewart D, Targonski A. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 1989;13: Vatterott PJ, Hammill SC, Bailey KR, Wiltgen CM, Gersh BJ. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol 1991;17: Baum RS, Alvarez H III, Cobb LA. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 1974;50: Myerburg RJ, Kessler KM, Zaman L, Conde CA, Castellanos A. Survivors of prehospital cardiac arrest. JAMA 1982;247:

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

More information

Arrhythmias Focused Review. Who Needs An ICD?

Arrhythmias Focused Review. Who Needs An ICD? Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes

More information

ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview

ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview Nabil El-Sherif, MD SUNY - Downstate Medical Center & New York harbor VA Healthcare System Brooklyn, NY, USA Signal Averaged ECG: A Selective

More information

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1 Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney

More information

Sudden death as co-morbidity in patients following vascular intervention

Sudden death as co-morbidity in patients following vascular intervention Sudden death as co-morbidity in patients following vascular intervention Impact of ICD therapy Seah Nisam Director, Medical Science, Guidant Corporation Advanced Angioplasty Meeting (BCIS) London, 16 Jan,

More information

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction

Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction Original Article Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction Masafumi Kanemura MD, Takao Katoh MD, Takashi Tanaka MD, Shin-ichiro

More information

Signal-Averaged Electrocardiography (SAECG)

Signal-Averaged Electrocardiography (SAECG) Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are

More information

What Every Physician Should Know:

What Every Physician Should Know: What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography

More information

Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era

Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era European Heart Journal (2005) 26, 755 761 doi:10.1093/eurheartj/ehi101 Clinical research Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era Axel

More information

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation J Arrhythmia Vol 25 No 1 2009 Original Article Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation Seiji Takashio

More information

The Multicenter Unsustained Tachycardia Trial (MUSTT)

The Multicenter Unsustained Tachycardia Trial (MUSTT) Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial Kerry L. Lee, PhD; Gail Hafley, MS; John D. Fisher, MD; Michael R. Gold, MD; Eric

More information

Management of Ventricular Arrhythmias A Trial-based Approach

Management of Ventricular Arrhythmias A Trial-based Approach Journal of the American College of Cardiology Vol. 34, No. 3, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00273-9 REVIEW

More information

Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction

Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction Journal of the American College of Cardiology Vol. 47, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.026

More information

Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life

Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge

More information

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Do All Patients With An ICD Indication Need A BiV Pacing Device? Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology

More information

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology

More information

Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia

Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia October 1999 513 Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia G.M. KAMALOV, A.S. GALYAVICH, N.R. KHASSANOV,

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.

More information

Are there low risk patients in Brugada syndrome?

Are there low risk patients in Brugada syndrome? Are there low risk patients in Brugada syndrome? Pedro Brugada MD, PhD Andrea Sarkozy MD Risk stratification in Brugada syndrome In the last years risk stratification in Brugada syndrome has become the

More information

journal of medicine The new england Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

journal of medicine The new england Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both The new england journal of medicine established in 1812 june 23, 2005 vol. 352 no. 25 Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both Scott

More information

QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators

QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.060

More information

Secondary prevention of sudden cardiac death

Secondary prevention of sudden cardiac death Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary

More information

Defibrillation threshold testing should no longer be performed: contra

Defibrillation threshold testing should no longer be performed: contra Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose

More information

The Italian Implantable Cardioverter- Defibrillator Registry. A survey of the national activity during the years

The Italian Implantable Cardioverter- Defibrillator Registry. A survey of the national activity during the years The Italian Implantable Cardioverter- Defibrillator Registry. A survey of the national activity during the years 2001-2003 Alessandro Proclemer, Marco Ghidina*, Gloria Cicuttini*, Dario Gregori*, Paolo

More information

Noninvasive Predictors of Sudden Cardiac Death

Noninvasive Predictors of Sudden Cardiac Death 2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial

More information

The Immediate Reproducibility of T Wave Alternans During Bicycle Exercise

The Immediate Reproducibility of T Wave Alternans During Bicycle Exercise Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

ICD Therapy. Disclaimers

ICD Therapy. Disclaimers ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.

More information

Pause-induced Ventricular Tachycardia: Clinical Characteristics

Pause-induced Ventricular Tachycardia: Clinical Characteristics Pause-induced Ventricular Tachycardia: Clinical Characteristics Margaret Bond A. Study Purpose and Rationale Until three decades ago, ventricular arrhythmias were thought to be rare in occurrence and their

More information

Summary, conclusions and future perspectives

Summary, conclusions and future perspectives Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular

More information

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology

More information

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology

More information

Presenter Disclosure Information

Presenter Disclosure Information Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Time to First Shock and Clinical Outcome in Patients Receiving an Automatic Implantable Cardioverter-Defibrillator

Time to First Shock and Clinical Outcome in Patients Receiving an Automatic Implantable Cardioverter-Defibrillator 508 Time to First Shock and Clinical Outcome in Patients Receiving an Automatic Implantable Cardioverter-Defibrillator ROBERT J. MYERBURG, MD, FACC, RICHARD M. LUCERI, MD, RICHARD THURER, MD, FACC, DEBORAH

More information

Significance of QRS duration in non-st elevation myocardial infarction.

Significance of QRS duration in non-st elevation myocardial infarction. Thomas Jefferson University Jefferson Digital Commons Cardiology Faculty Papers Department of Cardiology 5-6-2015 Significance of QRS duration in non-st elevation myocardial infarction. Chinualumogu Nwakile

More information

The concept of the implantable cardioverter-defibrillator (ICD) was introduced

The concept of the implantable cardioverter-defibrillator (ICD) was introduced Review Rohit Kedia, MD Mohammad Saeed, MD, FACC Implantable Cardioverter-Defibrillators Indications and Unresolved Issues Since the implantable cardioverter-defibrillator was first used clinically in 1980,

More information

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac

More information

Chapter 3. Eur Heart J 2009; 30:

Chapter 3. Eur Heart J 2009; 30: Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention ICD Recipients: Long-term Followup of the Leiden Out-of- Hospital Cardiac Arrest Study (LOHCAT) C. Jan Willem Borleffs, MD 1, Lieselot

More information

Zoll Medical--LifeVest:

Zoll Medical--LifeVest: Zoll Medical--LifeVest: Territory Manager: Sunny Brown Cell: (818) 916-6520 Objectives Why the LifeVest device exist Review indications for Wearable Cardioverter Defibrillator (WCD) use Give a brief description

More information

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

Cardiovascular disease is the leading cause of mortality in Western countries.

Cardiovascular disease is the leading cause of mortality in Western countries. Surgery for Acquired Cardiovascular Disease Holmes et al The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation

More information

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative

More information

Journal of the American College of Cardiology Vol. 44, No. 7, by the American College of Cardiology Foundation ISSN /04/$30.

Journal of the American College of Cardiology Vol. 44, No. 7, by the American College of Cardiology Foundation ISSN /04/$30. Journal of the American College of Cardiology Vol. 44, No. 7, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.063

More information

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off

More information

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #44 (NQF 0236): Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR

More information

Silvia G Priori MD PhD

Silvia G Priori MD PhD The approach to the cardiac arrest survivor Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular Genetics

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION ORIGINAL INVESTIGATION Effectiveness of Implantable Cardioverter-Defibrillators in Patients With Ischemic Heart Disease and Left Ventricular Dysfunction Paul S. Chan, MD, MSc; Theodore Chow, MD; Dean Kereiakes,

More information

Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry

Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry European Heart Journal (2003) 24, 1204 1209 Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Anton P.M. Gorgels*, Claudia Gijsbers, Jacqueline de

More information

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique

More information

Heart Rhythm Disorders. How do you quantify risk?

Heart Rhythm Disorders. How do you quantify risk? Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.

More information

Who does not need a primary preventive ICD?

Who does not need a primary preventive ICD? Who does not need a primary preventive ICD? Hildegard Tanner, Bern Universitätsklinik für Kardiologie Disclosure of potential conflicts of interest Travel grants for educational purposes from: Biosense

More information

Ventricular Arrhythmia After Cardiac Surgery

Ventricular Arrhythmia After Cardiac Surgery Journal of the American College of Cardiology Vol. 60, No. 25, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.1011

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11 Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias Markus Kowalsky Group 11 Selected Paper Ventricular arrhythmia is predicted by sum absolute QRST integral but not

More information

Practitioner Education Course

Practitioner Education Course 2015 Practitioner Education Course ST Elevation Myocardial Infarction 2 Pathology Concept of vulnerable plaque Mild Atheroma Diagnosis IVUS OCT 3 Diagnosis This is based on : Clinical History ECG Changes.

More information

Preventing Sudden Death Current & Future Role of ICD Therapy

Preventing Sudden Death Current & Future Role of ICD Therapy Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery

Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery 2618 Value of the P-Wave Signal-Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery Jonathan S. Steinberg, MD; Steven Zelenkofske, DO; Shing-Chiu Wong, MD; Mark Gelernt, MD; Robert Sciacca,

More information

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy

Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy 4 Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy Sirin Apiyasawat, Dujdao Sahasthas, Tachapong Ngarmukos, Pakorn Chandanamattha, Khanchit Likittanasombat

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Sudden cardiac death (SCD) is a

Sudden cardiac death (SCD) is a Management of malignant ventricular arrhythmias and cardiac arrest Richard I. Fogel, MD; Eric N. Prystowsky, MD Sudden cardiac death continues to be a major health problem in the United States, accounting

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

Atrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis

Atrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis Open Journal of Thoracic Surgery, 2012, 2, 18-22 http://dx.doi.org/10.4236/ojts.2012.22006 Published Online June 2012 (http://www.scirp.org/journal/ojts) Atrial Fibrillation Predicts Worse Long Time Prognosis

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials European Heart Journal (2000) 21, 2071 2078 doi.10.1053/euhj.2000.2476, available online at http://www.idealibrary.com on Meta-analysis of the implantable cardioverter defibrillator secondary prevention

More information

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:

More information

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Heart Failure and Implantable Cardioverter Defibrillator (ICD) Therapy: Update and Perspective on Current Primary Prevention Trials

Heart Failure and Implantable Cardioverter Defibrillator (ICD) Therapy: Update and Perspective on Current Primary Prevention Trials Journal of Cardiac Failure Vol. 8 No. 3 2002 Perspectives Heart Failure and Implantable Cardioverter Defibrillator (ICD) Therapy: Update and Perspective on Current Primary Prevention Trials LESLIE A. SAXON,

More information

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators Journal of the American College of Cardiology Vol. 53, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.10.053

More information

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance

More information

Risk Stratification of Sudden Cardiac Death

Risk Stratification of Sudden Cardiac Death Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of

More information

Journal of the American College of Cardiology Vol. 41, No. 12, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 41, No. 12, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 41, No. 12, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00467-4

More information

Journal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.

Journal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32. Journal of the American College of Cardiology Vol. 50, No. 11, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.05.035

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION

CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION *Bimmer Claessen, Loes Hoebers, José Henriques Department of Cardiology, Academic Medical Center, University of Amsterdam,

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Several studies of the primary prevention. Original Research

Several studies of the primary prevention. Original Research Original Research Hellenic J Cardiol 2015; 56: 230-236 Inducibility of Ventricular Arrhythmia and Tachyarrhythmia Recurrences in Patients with Implantable Defibrillator Giuseppe Stabile 1, Paolo Gallo

More information

EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION

EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION James R. Stewart,* John K. Gibson,? and Benedict R. Lucchesi t Departments of Internal Medicine *

More information

T-Wave Alternans. Policy # Original Effective Date: 06/05/2002 Current Effective Date: 09/17/2014

T-Wave Alternans. Policy # Original Effective Date: 06/05/2002 Current Effective Date: 09/17/2014 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, G. PAPANIKOLAOU GH, THESSALONIKI The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI CAD MOST COMMON CARDIOVASCULAR DISEASE MOST COMMON CAUSE OF DEATH

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

The International Classification of Diseases, Tenth Revision,

The International Classification of Diseases, Tenth Revision, AHA/ACCF/HRS Scientific Statement American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying

More information